Royce & Associates’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.35M | Hold |
|
|||||
|
2024
Q4 | $2.58M | Buy |
|
|||||
|
2024
Q3 | $1.08M | Hold |
|
|||||
|
2024
Q2 | $1.08M | Hold |
|
|||||
|
2024
Q1 | $1.15M | Buy |
|
|||||
|
2023
Q4 | $1.33M | Sell |
|
|||||
|
2023
Q3 | $2.81M | Buy |
|
|||||
|
2023
Q2 | $3.04M | Buy |
|
|||||
|
2023
Q1 | $3.1M | Buy |
|
|||||
|
2022
Q4 | $3.01M | Sell |
|
|||||
|
2022
Q3 | $2.73M | Buy |
|
|||||
|
2022
Q2 | $2.74M | Buy |
|
|||||
|
2022
Q1 | $2.86M | Buy |
|
|||||
|
2021
Q4 | $3.18M | Sell |
|
|||||
|
2021
Q3 | $2.95M | Sell |
|
|||||
|
2021
Q2 | $2.71M | Sell |
|
|||||
|
2021
Q1 | $2.76M | Buy |
|
|||||
|
2020
Q4 | $2.67M | Sell |
|
|||||
|
2020
Q3 | $2.66M | Buy |
|
|||||
|
2020
Q2 | $2.95M | Buy |
|
|||||
|
2020
Q1 | $3.13M | Buy |
|
|||||
|
2019
Q4 | $3.59M | Sell |
|
|||||
|
2019
Q3 | $3.19M | Buy |
|
|||||
|
2019
Q2 | $3.18M | Buy |
|
|||||
|
2019
Q1 | $2.93M | Buy |
|
|||||
|
2018
Q4 | $2.76M | Sell |
|
|||||
|
2018
Q3 | $3.13M | Sell |
|
|||||
|
2018
Q2 | $3.76M | Buy |
|
|||||
|
2018
Q1 | $3.37M | Sell |
|
|||||
|
2017
Q4 | $2.77M | Buy |
|
|||||
|
2017
Q3 | $2.51M | Sell |
|
|||||
|
2017
Q2 | $2.62M | Hold |
|
|||||
|
2017
Q1 | $2.25M | Hold |
|
|||||
|
2016
Q4 | $2.63M | Hold |
|
|||||
|
2016
Q3 | $2.17M | Sell |
|
|||||
|
2016
Q2 | $2.4M | Hold |
|
|||||
|
2016
Q1 | $2.38M | Hold |
|
|||||
|
2015
Q4 | $2.23M | Sell |
|
|||||
|
2015
Q3 | $2.21M | Hold |
|
|||||
|
2015
Q2 | $2.44M | Hold |
|
|||||
|
2015
Q1 | $2.45M | Buy |
|
|||||
|
2014
Q4 | $2.41M | Sell |
|
|||||
|
2014
Q3 | $2.16M | Buy |
|
|||||
|
2014
Q2 | $2.27M | Buy |
|
|||||
|
2014
Q1 | $2.52M | Buy |
|
|||||
|
2013
Q4 | $2.42M | Hold |
|
|||||
|
2013
Q3 | $2.51M | Hold |
|
|||||
|
2013
Q2 | $2.3M | Buy |
|